India’s most populous state to spend up to US$1.36b on Covid-19 shots amid shortage | Malay Mail

  • 📰 malaymail
  • ⏱ Reading Time:
  • 52 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 86%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

NEW DELHI, May 13— India’s most populous state will spend up to US$1.36 billion (RM5.6 billion) to buy Covid-19 shots and held early talks this week with companies such as Pfizer and the local partner of the maker of Russia’s Sputnik V, a state official said today. The move by Uttar Pradesh,...

Thursday, 13 May 2021 11:55 PM MYT

Uttar Pradesh has also held pre-bid talks with Indian vaccine companies the Serum Institute of India — licensed to make the AstraZeneca and Novavax shots — Bharat Biotech and Cadila Healthcare as part of a global tender to buy 40 million doses over the next few months, state spokesman Navneet Sehgal told Reuters.

Uttar Pradesh has also separately ordered 10 million doses of the AstraZeneca vaccine and Bharat Biotech’s Covaxin.Prime Minister Narendra Modi opened vaccinations to all adults from May 1, doubling the number of people eligible to an estimated 800 million, though domestic production will stay largely flat at about 80 million a month until July.

“Where is ‘India’? Portrays such a bad image of India. India, as one country, should procure vaccines on behalf of all Indian states.”Covid-19 immunisations in the country in the past week have hit levels last seen in mid-March when India did fewer than 2 million doses a day and vaccinations were limited to only health and front-line workers.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 1. in BUSİNESS

Business Business Latest News, Business Business Headlines